FNBT
BLUE

FineMark National Bank & Trust’s bluebird bio BLUE Stock Holding History

FineMark National Bank & Trust’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2
Closed -$1K – 1428
2013
Q4 		$1K Buy
+2
New +$559 ﹤0.01% 1405

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

FineMark National Bank & Trust's BLUE Position: Q1 2014 in Review

FineMark National Bank & Trust sold out of bluebird bio (BLUE) in Q1 2014, closing a stake of 2 shares — an estimated $1K sold.

FineMark National Bank & Trust first reported a position in BLUE in Q4 2013 and held it in 1 quarter. The position peaked at $1K in Q4 2013. 83 funds tracked by Wall St. Rank hold BLUE as of Q1 2014.

  • FineMark National Bank & Trust reported no remaining bluebird bio position as of Q1 2014 after selling out during the quarter.
  • FineMark National Bank & Trust sold 2 bluebird bio shares in Q1 2014, an estimated $1K.
  • FineMark National Bank & Trust first reported a position in bluebird bio in Q4 2013 and held it in 1 quarter.
  • FineMark National Bank & Trust's bluebird bio position peaked at $1K in Q4 2013.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q1 2014.

Based on FineMark National Bank & Trust's 13F filing for Q1 2014, filed 13 May 2014.